- increased circulating calcium level / IMPC
- increased leukocyte cell number / IMPC
- increased neutrophil cell number / IMPC
- increased monocyte cell number / IMPC
- increased granulocyte number / IMPC
- increased anti-nuclear antigen antibody level / IMPC
- increased eosinophil cell number / IMPC
- decreased B cell number / IMPC
- decreased T cell number / IMPC
- improved glucose tolerance / IMPC
- decreased circulating serum albumin level / IMPC
- decreased circulating thyroxine level / IMPC
- thrombocytosis / IMPC
- increased circulating creatinine level / IMPC
- decreased mean corpuscular hemoglobin / IMPC
- increased circulating total protein level / IMPC
- decreased CD8-positive, alpha-beta T cell number / IMPC
- decreased pre-B cell number / IMPC
- decreased mature B cell number / IMPC
- decreased immature B cell number / IMPC
- increased gamma-delta T cell number / IMPC
- increased red blood cell distribution width / IMPC
- decreased circulating fructosamine level / IMPC
- increased circulating magnesium level / IMPC
- increased CD4-positive, alpha-beta memory T cell number / IMPC
- increased CD8-positive, alpha-beta memory T cell number / IMPC
- increased effector memory CD8-positive, alpha-beta T cell number / IMPC
- decreased pre-pro B cell number / IMPC
- increased Ly6C high monocyte number / IMPC
- increased Ly6C low monocyte number / IMPC
- increased KLRG1+ CD8 alpha-beta T cell number / IMPC
- increased KLRG1+ CD4 alpha-beta T cell number / IMPC
- increased memory-marker gamma-delta T cell number / IMPC
- increased memory-marker NK cell number / IMPC
- increased memory-marker CD4-positive NK T cell number / IMPC
- increased CD103-positive CD11b-low dendritic cell number / IMPC
- increased effector memory T-helper cell number / IMPC
C57BL/6N-Atm1Brd Cxcr2tm1a(EUCOMM)Wtsi/WtsiOulu
Status | Available to order |
EMMA ID | EM:09700 |
Citation information | RRID:IMSR_EM:09700 Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information. |
International strain name | C57BL/6N-Atm1Brd Cxcr2tm1a(EUCOMM)Wtsi/WtsiOulu |
Alternative name | EPD0664_3_D02 |
Strain type | Targeted Mutant Strains |
Allele/Transgene symbol | Cxcr2tm1a(EUCOMM)Wtsi |
Gene/Transgene symbol | Cxcr2 |
Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
Provider | Wellcome Trust Sanger Institute |
Provider affiliation | Wellcome Trust Sanger Institute |
Genetic information | This mouse line originates from EUCOMM ES clone EPD0664_3_D02. For further details on the construction of this clone see the page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | University of Oulu, Oulu, Finland |
Disease and phenotype information
Orphanet associated rare diseases, based on orthologous gene matching
- Autosomal recessive severe congenital neutropenia due to CXCR2 deficiency / Orphanet_420699
IMPC phenotypes (allele matching)
IMPC phenotypes (gene matching)
- increased CD8-positive, alpha-beta memory T cell number / IMPC
- increased monocyte cell number / IMPC
- increased memory-marker gamma-delta T cell number / IMPC
- increased eosinophil cell number / IMPC
- increased neutrophil cell number / IMPC
- decreased pre-pro B cell number / IMPC
- increased circulating total protein level / IMPC
- increased gamma-delta T cell number / IMPC
- increased leukocyte cell number / IMPC
- increased KLRG1+ CD4 alpha-beta T cell number / IMPC
- increased circulating creatinine level / IMPC
- increased circulating magnesium level / IMPC
- improved glucose tolerance / IMPC
- increased granulocyte number / IMPC
- increased CD4-positive, alpha-beta memory T cell number / IMPC
- increased CD103-positive CD11b-low dendritic cell number / IMPC
- increased Ly6C high monocyte number / IMPC
- decreased CD8-positive, alpha-beta T cell number / IMPC
- increased effector memory T-helper cell number / IMPC
- decreased mature B cell number / IMPC
- increased circulating calcium level / IMPC
- decreased T cell number / IMPC
- decreased circulating thyroxine level / IMPC
- increased effector memory CD8-positive, alpha-beta T cell number / IMPC
- thrombocytosis / IMPC
- decreased B cell number / IMPC
- increased memory-marker NK cell number / IMPC
- increased anti-nuclear antigen antibody level / IMPC
- decreased mean corpuscular hemoglobin / IMPC
- decreased pre-B cell number / IMPC
- increased red blood cell distribution width / IMPC
- increased Ly6C low monocyte number / IMPC
- increased KLRG1+ CD8 alpha-beta T cell number / IMPC
- increased memory-marker CD4-positive NK T cell number / IMPC
- decreased circulating fructosamine level / IMPC
- decreased circulating serum albumin level / IMPC
- decreased immature B cell number / IMPC
MGI phenotypes (gene matching)
- increased leukocyte cell number / MGI
- increased neutrophil cell number / MGI
- extramedullary hematopoiesis / MGI
- increased granulocyte number / MGI
- small liver / MGI
- enlarged spleen / MGI
- enlarged lymph nodes / MGI
- abnormal myelination / MGI
- decreased oligodendrocyte progenitor number / MGI
- abnormal spinal cord morphology / MGI
- decreased body size / MGI
- decreased metastatic potential / MGI
- abnormal myelopoiesis / MGI
- abnormal respiratory mucosa goblet cell morphology / MGI
- abnormal airway responsiveness / MGI
- decreased airway responsiveness / MGI
- abnormal spleen white pulp morphology / MGI
- abnormal bone marrow morphology / MGI
- increased susceptibility to bacterial infection / MGI
- increased susceptibility to viral infection / MGI
- abnormal leukocyte physiology / MGI
- abnormal T cell physiology / MGI
- abnormal neutrophil physiology / MGI
- abnormal eosinophil physiology / MGI
- increased IgE level / MGI
- small adrenal glands / MGI
- delayed wound healing / MGI
- abnormal cytokine secretion / MGI
- decreased susceptibility to induced arthritis / MGI
- decreased tumor growth/size / MGI
- abnormal tumor morphology / MGI
- increased kidney weight / MGI
- decreased kidney weight / MGI
- increased seminal vesicle weight / MGI
- increased epididymis weight / MGI
- increased spleen weight / MGI
- decreased spleen weight / MGI
- decreased thymus weight / MGI
- increased B cell number / MGI
- increased susceptibility to parasitic infection / MGI
- immune system phenotype / MGI
- hematopoietic system phenotype / MGI
- decreased susceptibility to fungal infection / MGI
- abnormal T-helper 1 physiology / MGI
- abnormal T-helper 2 physiology / MGI
- corneal vascularization / MGI
- abnormal NK T cell physiology / MGI
- abnormal granulocyte differentiation / MGI
- enlarged cervical lymph nodes / MGI
- increased circulating interleukin-6 level / MGI
- impaired neutrophil recruitment / MGI
- impaired neutrophil chemotaxis / MGI
- abnormal chemokine level / MGI
- abnormal interleukin level / MGI
- decreased sensitivity to induced morbidity/mortality / MGI
- decreased susceptibility to bacterial infection induced morbidity/mortality / MGI
- myeloid hyperplasia / MGI
- lymph node medullary cord hyperplasia / MGI
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).